Image

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

Testing BL-M14D1 for advanced lung and neuroendocrine tumors.

Recruiting
18 years and older
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is testing a drug called **BL-M14D1** to see how safe and effective it is for people with certain types of advanced lung and neuroendocrine cancers. Neuroendocrine tumors are a type of cancer that affects hormone-producing cells. The study is open-label, meaning everyone knows they are receiving the study drug, and it is Phase 1, which is the first stage of testing in humans.

  • The study involves multiple visits to the clinic and will monitor your health closely.
  • Participants must have specific types of cancer and have tried at least one standard treatment before.
  • There are some risks, like side effects from the drug, and you can't join if you recently had other cancer treatments or have certain health conditions.
Print
Study details
    Small Cell Lung Cancer Metastatic or Locally Advanced
    Neuroendocrine Cancer
    Metastatic Neuroendocrine Prostate Cancer
    Metastatic Advanced Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinoma
    Metastatic Advanced Merkel Cell Carcinoma
    Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung
    Locally Advanced Extrapulmonary Neuroendocrine Carcinoma
    Locally Advanced Neuroendocrine Prostate Cancer
    Locally Advanced Poorly Differentiated Gastroenteropancreatic Neuroendocrine
    Locally Advanced Merkel Cell Carcinoma
    Metastatic Large Cell Neuroendocrine Carcinoma of the Lung

NCT07080242

SystImmune Inc.

17 October 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.